Merck Sharp & Dohme LLC v. Halozyme Inc

Jeffrey Kushan

Merck challenges Halozyme's PH20 polypeptide patent, arguing all 40 claims lack enablement, written description, and are obvious over prior art.

Judge	Cases	Inst. Rate	FWD Inv. Rate
Jeffrey N Fredman	100+	74%	85%
Michaela Valek	100+	59%	70%
Susan L C Mitchell	600+	64%	66%

Name	Ratings
Sterne Kessler Goldstein & Fox	L5 A
Ralph W. Powers, III	L5 B
Eldora L. Ellison	L4 E
Jennifer Chagnon	-- -- --
Tyler C. Liu	-- -- --
Quinn Emanuel Urquhart & Sullivan LLP	L5 E
Lauren N. Martin	-- -- --